Cellecta

Cellecta, Inc. is dedicated to developing advanced high-throughput (HT) genetic screening technologies and their applications in the discovery and functional characterization of novel therapeutic targets and drugs. The company provides pooled lentiviral shRNA and CRISPR libraries, NGS-based pooled library screening and analysis, targeted RNA-Seq for biomarker discovery, lentiviral reagents, stable cDNA, shRNA and CRISPR constructs, and isogenic cell lines.